Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo and Comparator-Controlled, Dose-Response Trial of the Efficacy and Safety of Intranasal Morphine, Intravenous Morphine and Placebo in Patients With Moderate to Severe Pain Following Orthopedic Surgery

NCT00388011 is registered in ClinicalTrials.gov with Javelin Pharmaceuticals as lead sponsor.

NCT NCT00388011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00388011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo and Comparator-Controlled, Dose-Response Trial of the Efficacy and Safety of Intranasal Morphine, Intravenous Morphine and Placebo in Patients With Moderate to Severe Pain Following Orthopedic Surgery
Lead sponsor
Javelin Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
August 31, 2005
Enrollment
187 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hallux valgus